4 completed. 4 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 4 | Completed 4 |
Follow Ischemic Attack, Transient: new trials by email Literature Review of Ischemic Attack, Transient trials Research Report on Ischemic Attack, Transient
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Optimal Blood Pressure and Cholesterol Targets for Preventing Recurrent Stroke in Hypertensives all approved antihypertensive drugs; all approved statins - Stroke, Transient Ischemic Attack | Phase 4 | Completed | Istituto Auxologico Italiano | 200 | 2013-04-01 | 2024-02-20 |
| Efficacy and Cost-Effectiveness of Cost-free Pharmacotherapy for Smoking Cessation for High-risk Smokers With Cerebrovascular Disease Cost-Free Pharmacotherapy Group, Prescription Only Group - Cerebrovascular Disorders, Smoking Cessation | Phase 4 | Completed | Ottawa Heart Institute Research Corporation | 194 | 2009-12-01 | 2026-08-10 |
| Preventing Recurrent Vascular Events in Patients With Stroke or Transient Ischemic Attack Antihypertensive agents and lipid lowering therapy, Usual Care - Ischemic Stroke, Transient Ischemic Attacks | Phase 4 | Completed | University of Alberta | 279 | 2009-01-01 | 2018-10-15 |
| ESPRIT: European/Australasian Stroke Prevention in Reversible Ischaemia Trial anticoagulation, aspirin and dipyridamole, aspirin alone - Brain Ischemia, Transient Ischemic Attack | Phase 4 | Completed | UMC Utrecht | 4500 | 1997-07-01 | 2007-03-22 |
Stroke (3) · Arteriosclerosis (1) · Brain Ischemia (1) · Cerebrovascular Disorders (1) · Dementia (1) · Heart Failure (1) · Hypertension (1) · Ischemic Stroke (1) · Myocardial Infarction (1) · Smoking Cessation (1)
Brain Diseases (4) · Cardiovascular Diseases (4) · Central Nervous System Diseases (4) · Nervous System Diseases (4) · Vascular Diseases (4) · Brain Ischemia (3) · Cerebrovascular Disorders (3) · Arterial Occlusive Diseases (1) · Behavior (1) · Health Behavior (1) · Heart Diseases (1) · Infarction (1) · Ischemia (1) · Mental Disorders (1) · Myocardial Ischemia (1)
Adrenergic alpha-Antagonists (1) · Adrenergic beta-Antagonists (1) · Angiotensin Receptor Antagonists (1) · Angiotensin-Converting Enzyme Inhibitors (1) · Antihypertensive Agents (1) · Aspirin (1) · Atorvastatin (1) · Bupropion (1) · Calcium Channel Blockers (1) · Dipyridamole (1) · Fluvastatin (1) · Mineralocorticoid Receptor Antagonists (1) · Pravastatin (1) · Rosuvastatin Calcium (1) · Simvastatin (1)
Istituto Auxologico Italiano (1) · Ottawa Heart Institute Research Corporation (1) · UMC Utrecht (1) · University of Alberta (1)
Canada (2) · Netherlands (1) · Russia (1)
A. Algra, Professor (1) · Alberto Zanchetti (1) · Andrew Pipe, MD (1) · Debbie Aitken, RN BScN (1) · Finlay A McAlister, MD, MSc (1) · Grant Stotts, MD (1) · J. Gijn Van, Professor (1) · Kerri-Anne Mullen, MSc (1) · Lisheng Liu, MD (1) · Mary Ann Laplante, RN BScN (1) · Robert Reid, MBA PhD (1) · Sophia Gocan, RN BScN (1) · Sophia Papadakis, MHA (1)
PMID 16714187, PMID 17239798, PMID 21330625, PMID 24733770, PMID 24979303, PMID 25458657, PMID 32905623, PMID 36398903